Gibraltar Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,725
Closed -$749K 71
2022
Q4
$749K Sell
8,725
-223
-2% -$17.7K 0.35% 37
2022
Q3
$552K Buy
8,948
+2,691
+43% +$170K 0.28% 40
2022
Q2
$387K Buy
6,257
+123
+2% +$7.62K 0.19% 54
2022
Q1
$365K Buy
6,134
+1,927
+46% +$123K 0.15% 71
2021
Q4
$305K Buy
+4,207
New +$290K 0.14% 65
2016
Q4
Sell
-52,640
Closed -$4.17M 32
2016
Q3
$4.17M Buy
52,640
+1,392
+3% +$113K 4.81% 7
2016
Q2
$4.28M Sell
51,248
-642
-1% -$57K 5.26% 4
2016
Q1
$4.77M Buy
51,890
+13,267
+34% +$1.2M 6.41% 4
2015
Q4
$3.91M Sell
38,623
-1,595
-4% -$166K 4.85% 6
2015
Q3
$3.95M Buy
40,218
+16,246
+68% +$1.8M 4.88% 5
2015
Q2
$2.81M Sell
23,972
-2,099
-8% -$229K 2.99% 19
2015
Q1
$2.56M Buy
+26,071
New +$2.65M 2.42% 24

Other funds holding GILD

Gibraltar Capital Management's GILD Position: Q1 2023 in Review

Gibraltar Capital Management sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 8,725 shares — an estimated $749K sold.

Gibraltar Capital Management first reported a position in GILD in Q1 2015 and held it in 12 quarters. The position peaked at $4.77M in Q1 2016. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Gibraltar Capital Management reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Gibraltar Capital Management sold 8,725 Gilead Sciences shares in Q1 2023, an estimated $749K.
  • Gibraltar Capital Management first reported a position in Gilead Sciences in Q1 2015 and held it in 12 quarters.
  • Gibraltar Capital Management's Gilead Sciences position peaked at $4.77M in Q1 2016.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Gibraltar Capital Management's 13F filing for Q1 2023, filed 8 May 2023.